BRITISH pharmaceutical giant GlaxoSmithKline today announced soaring annual profits thanks to the demerger of its consumer healthcare unit Haleon.
Net profit surged to £14.9 billion (RM78 billion) last year from £4.4 billion in 2021, GSK said in a statement.